Breast Studies
CCTG MA.39 Tailor RT
Principal Investigator: Sheema Chawla, MD
Title: Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Locations: Rochester General Hospital and Linden Oaks
Status: Accruing
ClinicalTrials.gov Link: NCT03488693
Gilead ASCENT- 05
Principal Investigator: Farhan Imran, MD
Title: A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician’s Choice in Patients with Triple Negative Breast Cancer who have Residual Invasive Disease after Surgery and Neoadjuvant Therapy
Locations: Rochester General Hospital and Linden Oaks
Status: Accruing
ClinicalTrials.gov Link: NCT05633654
ROSETTA Breast-01
Principal Investigator: Rachel David, MD
Title: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease.
Locations: Rochester General Hospital and Linden Oaks
Status: Accruing
ClinicalTrials.gov Link: NCT07173751
Hematological Neoplasms and Disorder Studies
MM Registry
Principal Investigator: Saad Jamshed, MD
Title: Observational Registry Collecting Data on Patients Diagnosed with Multiple Myeloma
Locations: Rochester General Hospital, Linden Oaks, and Unity Hospital
Status: Accruing
MYELOMATCH
Principal Investigator: Maria Sbenghe, MD
Title: MYELOMATCH, Master Screening and Reassessment Protocol (MSRP) for Tier Advancement in the NCI MyeloMATCH Clinical Trials
Locations: Rochester General Hospital
Status: Accruing
ClinicalTrials.gov Link: NCT05564390
SID Registry
Principal Investigator: Saad Jamshed, MD
Title: Secondary Immunodeficiency (SID) Registry for Chronic Lymphocytic Leukemia, Lymphoma, and Multiple Myeloma
Locations: Rochester General Hospital and Linden Oaks
Status: Accruing
Thoracic Studies
Alliance A081801
Principal Investigator: Mehul Patel, MD
Title: Integration of Immunotherapy into Adjuvant Therapy for Resected Non-Small Cell Lung Cancer: ALCHEMIST CHEMO-IO (ACCIO)
Locations: Rochester General Hospital and Linden Oaks
Status: Accruing
IZABRIGHT-Lung01 (CA244-0010)
Principal Investigator: Mehul Patel, MD
Title:A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.
Locations: Rochester General Hospital and Linden Oaks
Status: Accruing
ClinicalTrials.gov Link: NCT07100080
Gastrointestinal Studies
ALLIANCE A032103 MODERN
Principal Investigator: Maria Sbenghe, MD
Title: MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
Locations: Rochester General Hospital, Linden Oaks, and Unity Hospital
Status: Accruing
ClinicalTrials.gov Link: NCT05987241
ECOG-ACRIN EA2192 APOLLO
Principal Investigator: Amy Bodrog, MD
Title: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Locations: Rochester General Hospital, Linden Oaks, and Unity Hospital
Status:Accruing
ClinicalTrials.gov Link: NCT04858334
NRG-GI008 CIRCULATE-US
Principal Investigator: Mohammad Talal Khan, DO
Title: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Locations: Rochester General Hospital, Linden Oaks, and Unity Hospital
Status: Accruing
ClinicalTrials.gov Link: NCT05174169
Supportive Care Studies
AYA NEEDS STUDY
Principal Investigator: Amy Bodrog, MD
Title:Adolescents and Young Adults with Cancer: Needs Exploration, Experiences, Determinants, and Support (AYA-NEEDS), Local Collaboration.
Locations: Rochester General Hospital, Linden Oaks, and Unity Hospital
Status: Accruing
Locations
Lipson Cancer Institute – Rochester General Hospital
1425 Portland Avenue
Rochester, NY 14621
Lipson Cancer Institute – Linden Oaks
20 Hagen Drive
Suite 100
Rochester, NY 14625
Lipson Cancer Institute – Unity Hospital
1561 Long Pond Road
Suite 120
Rochester, NY 14626
If you would like more information about research studies, please reach out to our staff via email or phone.